- Home
- FRGT vs DRMA Comparison
FRGT vs DRMA Comparison
Compare FRGT & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- DRMA
- Stock Information
- Founded
- FRGT 2015
- DRMA 2014
- Country
- FRGT Mexico
- DRMA United States
- Employees
- FRGT N/A
- DRMA N/A
- Industry
- FRGT Professional Services
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- DRMA Health Care
- Exchange
- FRGT Nasdaq
- DRMA Nasdaq
- Market Cap
- FRGT 4.2M
- DRMA 3.5M
- IPO Year
- FRGT N/A
- DRMA 2021
- Fundamental
- Price
- FRGT $1.20
- DRMA $5.48
- Analyst Decision
- FRGT
- DRMA Strong Buy
- Analyst Count
- FRGT 0
- DRMA 1
- Target Price
- FRGT N/A
- DRMA $10.00
- AVG Volume (30 Days)
- FRGT 76.6K
- DRMA 28.3K
- Earning Date
- FRGT 08-18-2025
- DRMA 08-13-2025
- Dividend Yield
- FRGT N/A
- DRMA N/A
- EPS Growth
- FRGT N/A
- DRMA N/A
- EPS
- FRGT N/A
- DRMA N/A
- Revenue
- FRGT $12,693,870.00
- DRMA N/A
- Revenue This Year
- FRGT $371.03
- DRMA N/A
- Revenue Next Year
- FRGT N/A
- DRMA N/A
- P/E Ratio
- FRGT N/A
- DRMA N/A
- Revenue Growth
- FRGT N/A
- DRMA N/A
- 52 Week Low
- FRGT $1.15
- DRMA $5.09
- 52 Week High
- FRGT $23.31
- DRMA $24.90
- Technical
- Relative Strength Index (RSI)
- FRGT 23.66
- DRMA 37.22
- Support Level
- FRGT $1.15
- DRMA $5.09
- Resistance Level
- FRGT $1.58
- DRMA $6.09
- Average True Range (ATR)
- FRGT 0.10
- DRMA 0.52
- MACD
- FRGT -0.01
- DRMA -0.09
- Stochastic Oscillator
- FRGT 8.33
- DRMA 20.22
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.